Digital Therapeutics Market - Global Forecast to 2021

Jul 1, 2016 - Markets and Markets - 191 pages - USD $5,650
Report Summary Table of Contents Request Details Related
Digital Therapeutics Market by Application (Prevention (Prediabetes, Obesity), Care (Diabetes, CVD, CNS, CRD, Smoking Cessation, Musculoskeletal)), Sales Channel (B2C (Patient, Caregiver), B2B (Provider, Payer, Employer, Pharma)) - Global Forecast to 2021

The digital therapeutics market in terms of value is expected to reach USD 457.9 million by 2021 from USD 110 million in 2016, growing at a CAGR of 27.7% from 2016 to 2021. This market is categorized on the basis of application, sales channel, and region.

Major factors contributing to the growth of the digital therapeutics market include increasing incidence of chronic diseases, rising focus on preventive healthcare, technological advancements, growing need to control healthcare costs, significant increase in venture capital investments, and the benefits of digital therapeutics. Government initiatives to support the development and adoption of digital therapeutics solutions also provide an impetus for the growth of this market. For instance, in 2010, the U.S. Congress authorized the Centers for Disease Control and Prevention (CDC) to create the Diabetes Prevention Recognition Program (DPRP) and recognize programs that meet evidence-based standards provided by DPRP. This includes programs such as the "Prevent" program offered by Omada Health Inc. (U.S.) implemented for the prevention of diabetes. Additionally, the Affordable Care Act (2010) authorized a series of diabetes prevention programs under the National Diabetes Prevention Program (NDPP). One example of such a program is three digital diabetes prevention programs, provided by Canary Health (U.S.), Noom Health (U.S.), and Omada Health (U.S.), which received recognition in 2015. Such government initiatives are likely to provide an impetus for market growth. Relatively untapped markets in developing regions of Asia-Pacific and unexplored therapeutic applications have opened an array of opportunities for the digital therapeutics market. However, factors such as a lack of awareness and access to digital therapeutics programs in developing countries, patient data privacy concerns, and resistance from traditional healthcare providers may restrain the growth of this market.

Apart from the comprehensive geographical and product analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by industry players over the last three years. In addition, the company profiles comprise basic views on key players in the digital therapeutics market and their product portfolios, developments, and strategies. The above-mentioned market research data, current market size, and forecast of the future trends will help key players and new entrants to make the necessary decisions regarding product offerings, geographical focus, changes in strategic approach, R&D investments for innovations in products and technologies, and levels of output in order to remain successful.

Reasons to Buy the Report:

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms garner a greater market share. Firms purchasing the report can use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:
  • Market Penetration: Comprehensive information on the product portfolios of top players in the digital therapeutics market. The report analyzes the digital therapeutics market by application, sales channel, and region
  • Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and new product launches in the digital therapeutics market
  • Competitive Assessment: In-depth assessment of market strategies, geographical and business segments, and product portfolios of leading players in the digital therapeutics market
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the market for various digital therapeutics products across geographies
  • Market Diversification: Exhaustive information about new products and services, untapped geographies, recent developments, and investments in the digital therapeutics market

Order Today!
FORMAT: Single User PDF - Delivered by Email $5,650 USD
LICENSE: Single User
DELIVERY: By Email - 1 Business Day


The Fast Market Research Advantage
Only the Best
All of our research is sourced from the most trusted and established global analysts and consultancies

Client Focused
From start-ups to multinationals, we focus on providing the right research to our diverse client base

Shop Securely
Our US-based customer service team and eCommerce systems adhere to the highest data security standards

Industry-leading Customer Support
Individualized assistance from our expert staff is never more than an email or phone call away


BEST PRICE GUARANTEE
We are committed to providing the best research at the lowest cost. We will match any published price for the same report, guaranteed!

EASY ORDERING
Once you’ve found the right report, click ‘order now’ and complete the checkout process using any major credit card, check or wire/bank transfer.

Need multi-user or enterprise license pricing? Contact us for a custom quote!
MC, Visa, AMEX, Diners, Discovery, JCB

About the Publisher
MarketsandMarkets (M&M) is a global market research and consulting company based in the U.S. The company publishes high-level strategically analyzed reports for over ten industry verticals and serves as a business intelligence partner to Fortune 500 companies across the world.